Original Chrono-moxibustion adjusts circadian rhythm of CLOCK and BMAL1 in adjuvant-induced arthritic rats

被引:0
作者
He, Xinling [1 ]
Yu, Mingfang [1 ,2 ]
Zhao, Jiasong [3 ]
Wang, Aiyang [1 ]
Yin, Ji [1 ]
Wang, Haoyu [1 ]
Qiu, Jiao [1 ]
He, Xueyi [1 ]
Wu, Xiao [1 ,4 ]
机构
[1] Southwest Med Univ, Affiliated Tradit Chinese Med Hosp, Luzhou 646000, Sichuan, Peoples R China
[2] Luzhou TCM Hosp, Luzhou 646000, Sichuan, Peoples R China
[3] Hosp Chengdu Univ Tradit Chinese Med, Chengdu 610072, Sichuan, Peoples R China
[4] Southwest Med Univ, Affiliated Tradit Chinese Med Hosp, 16 Chunhui Rd, Luzhou 646000, Sichuan, Peoples R China
来源
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH | 2022年 / 14卷 / 07期
基金
中国国家自然科学基金;
关键词
Rheumatoid arthritis; chrono-moxibustion; clock gene; CLOCK; BMAL1; circadian rhythm; MODIFIED-RELEASE PREDNISONE; RHEUMATOID-ARTHRITIS; EXPRESSION; CHRONOTHERAPY; ALPHA;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The clinical symptoms of rheumatoid arthritis (RA) have significant circadian rhythms, with morning stiffness and joint pain. Moxibustion is effective in the treatment of RA, while the underlying therapeutic mechanisms remain limited. Thus, we explored whether moxibustion could adjust the circadian rhythm of RA by modulating the core clock genes CLOCK and BMAL1 at the molecular level. Methods: 144 Sprague Dawley rats were randomly divided into four groups: control group (group A), model group (group B), 7-9 am moxibustion treatment group (group C), and 5-7 pm moxibustion treatment group (group D). Each group was divided into 6 time points (0 am, 4 am, 8 am, 12 N, 6 pm, and 8 pm) with an equal number of rats at each time point. Except for group A, all rats were injected with Freund's Complete Adjuvant (FCA) 0.15 ml on the right foot pad to establish the RA model. The rats of the two moxibustion treatment groups were respectively subjected to moxibustion at 7-9 am and 5-7 pm. After 3 weeks of treatment, the tissues were collected at 6 time points during the next 24 hours. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was used to test the mRNA expression of CLOCK and BMAL1 in the hypothalamus and synovial tissues. CLOCK and BMAL1 protein expression in synovial tissues were detected with western blot. Results: Compared to group A, group B showed significantly down-regulated expression levels of CLOCK and BMLA1 at synovial tissue (P < 0.05), while no statistically significant difference was found in the hypothalamus (P > 0.05). The expression levels of CLOCK and BMLA1 were up-regulated in the moxibustion treatment groups in different tissues, especially in synovial tissue (P < 0.05) compared to group B. Nevertheless, no difference was observed between groups C and D (P > 0.05). Conclusions: Moxibustion could treat RA by modulating clock core genes CLOCK and BMAL1 to regulate the circadian rhythm. However, there was no significant difference between the 7-9 am moxibustion treatment group and the 5-7 pm moxibustion treatment group. This study provides a basis for research on moxibustion in the treatment of RA.
引用
收藏
页码:4880 / 4897
页数:18
相关论文
共 34 条
  • [1] Clock gene expression in different synovial cells of patients with rheumatoid arthritis and osteoarthritis
    Becker, Tatjana
    Tohidast-Akrad, Makiyeh
    Humpeler, Susanne
    Gerlag, Danielle M.
    Kiener, Hans-Peter
    Zenz, Peter
    Steiner, Guenter
    Ekmekcioglu, Cem
    [J]. ACTA HISTOCHEMICA, 2014, 116 (07) : 1199 - 1207
  • [2] Chronotherapy with low-dose modified-release prednisone for the management of rheumatoid arthritis: a review
    Beltrametti, Stefano Paolo
    Ianniello, Aurora
    Ricci, Clara
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1763 - 1776
  • [3] Health Care Effect of Disease-Modifying Antirheumatic Drug Use on Patients with Rheumatoid Arthritis
    Boytsov, Natalie N.
    Bhattacharya, Ritupurna
    Saverno, Kim
    Dixon, Laurin
    Abbott, Paul L.
    Zhang, Xiang
    Gaich, Carol L.
    Nair, Radhika
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (08) : 879 - 887
  • [4] Small Molecule Modulators of the Circadian Molecular Clock With Implications for Neuropsychiatric Diseases
    Cha, Hyo Kyeong
    Chung, Sooyoung
    Lim, Hye Young
    Jung, Jong-Wha
    Son, Gi Hoon
    [J]. FRONTIERS IN MOLECULAR NEUROSCIENCE, 2019, 11
  • [5] DNA Methylation as a Future Therapeutic and Diagnostic Target in Rheumatoid Arthritis
    Ciechomska, Marzena
    Roszkowski, Leszek
    Maslinski, Wlodzimierz
    [J]. CELLS, 2019, 8 (09)
  • [6] Glucocorticoids and chronotherapy in rheumatoid arthritis
    Cutolo, Maurizio
    [J]. RMD OPEN, 2016, 2 (01):
  • [7] Circadian variations in clinical symptoms and concentrations of inflammatory cytokines, melatonin, and cortisol in polymyalgia rheumatica before and during prednisolone treatment: a controlled, observational, clinical experimental study
    Galbo, Henrik
    Kall, Lisbeth
    [J]. ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [8] Effect of Moxibustion on HIF-1α and VEGF Levels in Patients with Rheumatoid Arthritis
    Gong, Yuanyuan
    Yu, Zeyun
    Wang, Yingni
    Xiong, Yan
    Zhou, Yumei
    Liao, Chen-xi
    Li, Yuan
    Luo, Yun
    Bai, Yu
    Chen, Bailu
    Tang, Yuzhi
    Wu, Ping
    [J]. PAIN RESEARCH & MANAGEMENT, 2019, 2019
  • [9] The circadian regulator Bmal1 in joint mesenchymal cells regulates both joint development and inflammatory arthritis
    Hand, Laura E.
    Dickson, Suzanna H.
    Freemont, Anthony J.
    Ray, David W.
    Gibbs, Julie E.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [10] The circadian clock regulates inflammatory arthritis
    Hand, Laura E.
    Hopwood, Thomas W.
    Dickson, Suzanna H.
    Walker, Amy L.
    Loudon, Andrew S. I.
    Ray, David W.
    Bechtold, David A.
    Gibbs, Julie E.
    [J]. FASEB JOURNAL, 2016, 30 (11) : 3759 - 3770